Solesis Acquires Polyzen

November 2, 2022

Cleary Gottlieb represented Solesis LLC (Solesis) in its acquisition of Polyzen LLC (Polyzen).

The transaction terms have not been publicly disclosed. The transaction signed and closed on November 2, 2022.

Cleary previously represented Altaris in its acquisition of a majority equity stake in Solesis.

Solesis is a market leader specializing in biomaterials for the life sciences industry. Operating through its subsidiaries—Secant Group, Polyzen, and Charter Medical—Solesis develops, manufactures, and sells critical components for implantable medical devices and single-use technologies for the biopharmaceutical market, including cell and gene therapies.

Polyzen is a leading contract developer and manufacturer of custom medical-grade polymer components and products for the medical device and specialty industrial markets worldwide. With fully equipped facilities in Apex, North Carolina, Polyzen develops concepts from prototype to full-scale production with a variety of technologies and services to meet demanding application and regulatory challenges.

For more information, please see the press release here.